Global Manufacturer Of Cyclopropylboronic Acid For API Synthesis
- NINGBO INNO PHARMCHEM supplies industrial-purity Cyclopropylboronic Acid (≥97%) with full COA, GMP-aligned documentation, and scalable batch sizes for global API manufacturers.
- Our optimized synthesis route ensures superior stability and reactivity in Suzuki-Miyaura cross-coupling reactions—critical for complex pharmaceutical intermediates.
- Bulk pricing, cold-chain logistics, and custom packaging (from 25g to 25kg) support seamless integration into regulated drug development pipelines worldwide.
In modern pharmaceutical development, the demand for reliable, high-performance organoboron compounds has surged—particularly for use in palladium-catalyzed cross-coupling reactions. Among these, Cyclopropylboronic Acid (CAS: 411235-57-9), also known as cyclopropaneboronic acid or (cyclopropyl)boronic acid, stands out as a pivotal building block in the synthesis of bioactive molecules. Its strained three-membered ring imparts unique steric and electronic properties that enhance metabolic stability and binding affinity in active pharmaceutical ingredients (APIs). As a global manufacturer specializing in fine chemical intermediates, NINGBO INNO PHARMCHEM CO.,LTD. delivers this critical Suzuki coupling reagent with consistent industrial purity, rigorous quality control, and end-to-end supply chain reliability.
Why Cyclopropylboronic Acid Is Indispensable in API Synthesis
The cyclopropyl moiety is increasingly prevalent in FDA-approved drugs and clinical candidates due to its ability to modulate pharmacokinetics without significantly increasing molecular weight. When incorporated via Suzuki-Miyaura coupling—a cornerstone of modern C–C bond formation—Cyclopropylboronic Acid enables efficient access to aryl-cyclopropyl architectures found in antiviral agents, kinase inhibitors, and CNS therapeutics.
However, not all commercial sources meet the stringent demands of GMP-compliant API manufacturing. Impurities such as boroxines, residual solvents, or inorganic boron species can drastically reduce reaction yields or introduce genotoxic risks. This underscores the need for a trusted global manufacturer capable of delivering material with documented consistency, traceability, and reactivity.
When sourcing high-purity Cyclopropylboronic Acid, buyers should prioritize suppliers who provide comprehensive Certificates of Analysis (COA), synthetic route transparency, and regulatory support files—including Drug Master Files (DMFs) where applicable.
Optimized Manufacturing Process for Industrial Purity and Scalability
At NINGBO INNO PHARMCHEM, our manufacturing process for Cyclopropylboronic Acid is engineered for both performance and scalability. Starting from high-quality cyclopropylmagnesium bromide (Grignard reagent), we employ controlled transmetallation with trialkyl borates under inert atmosphere, followed by careful hydrolysis and crystallization protocols. This approach minimizes side-product formation and ensures a final product with ≥97% purity by HPLC—well above industry benchmarks.
Key advantages of our synthesis route include:
- Reduced boroxine content: Our proprietary workup suppresses cyclic anhydride (boroxine) formation, which can otherwise complicate stoichiometry in coupling reactions.
- Low residual metals: ICP-MS testing confirms metal impurities (Pd, Ni, Fe) below 10 ppm—critical for catalyst-sensitive transformations.
- Batch-to-batch reproducibility: All lots undergo NMR, HPLC, and Karl Fischer titration to verify identity, purity, and water content (<0.5%).
This level of control makes our material ideal as an API synthesis intermediate in regulated environments, where deviations can trigger costly batch failures or regulatory delays.
Supply Chain Excellence: Cold-Chain Logistics and Flexible Packaging
Cyclopropylboronic Acid is moisture- and temperature-sensitive, requiring strict storage below –20°C to prevent decomposition. Recognizing this, we’ve integrated cold-chain logistics into our global distribution model—ensuring stability from factory to lab bench.
We offer multiple packaging configurations tailored to R&D, pilot-scale, and commercial production needs:
| Package Size | Container Type | Storage Recommendation | Ideal For |
|---|---|---|---|
| 25g – 500g | Sealed aluminum foil bag with desiccant | –20°C, under argon | Route scouting, analytical standards |
| 1kg – 5kg | Double-layer foil bag in fiber drum | –20°C, dry ice during transit | Preclinical & Phase I trials |
| 10kg – 25kg | Vacuum-sealed HDPE liner in fiber can | –20°C, validated cold-chain shipping | Commercial API manufacturing |
All shipments include real-time temperature monitoring and are compliant with IATA/ADR regulations for hazardous organoboron materials. Lead times average 5–10 business days globally, with expedited options available for urgent campaigns.
Regulatory Documentation and Technical Support
As a top-tier supplier to multinational pharma companies, we understand that documentation is as critical as the molecule itself. Every batch of our organoboron compound is accompanied by:
- Certificate of Analysis (COA) with full spectral data (¹H/¹³C NMR, HPLC chromatogram)
- Safety Data Sheet (SDS) compliant with GHS and REACH
- Statement of Manufacture under ISO 9001:2015 quality management systems
- Optional: CEP (Certificate of Suitability) support or Type II DMF filing upon request
Our technical team—comprising PhD-level synthetic chemists—provides application-specific guidance on handling, reaction setup, and troubleshooting low-yielding couplings. Whether you’re optimizing a novel kinase inhibitor or scaling up a generic API, we ensure your synthesis route benefits from maximum efficiency and minimal attrition.
Bulk Pricing and Commercial Advantages
Through vertical integration and process intensification, we offer competitive bulk price structures without compromising on quality. Volume discounts apply at 5kg+, with additional savings for annual supply agreements. Unlike fragmented or trading-based suppliers, we control the entire value chain—from raw material sourcing to final QC—enabling predictable costs and uninterrupted supply.
For example, our current bulk pricing (FOB Ningbo) is structured as follows:
| Quantity | Price Range (USD/kg) | Includes |
|---|---|---|
| 1–5 kg | $420 – $480 | COA, SDS, standard packaging |
| 5–25 kg | $360 – $410 | Full analytical package, cold-chain shipping |
| 25+ kg | Custom quote | DMF support, dedicated QC batch, long-term contract terms |
Free samples (1–5g) are available for qualified customers to validate performance in their specific reaction system.
Conclusion: Partnering with a Trusted Global Manufacturer
In the high-stakes world of pharmaceutical synthesis, the choice of intermediate supplier directly impacts timeline, cost, and regulatory success. Cyclopropylboronic Acid may appear as a simple reagent on paper, but its performance in Suzuki coupling hinges on subtle factors—purity profile, hydration state, and trace impurities—that only a vertically integrated, chemistry-driven manufacturer can reliably control.
NINGBO INNO PHARMCHEM CO.,LTD. combines deep synthetic expertise, ISO-certified operations, and global logistics to deliver this essential pharmaceutical intermediate with unmatched consistency. Whether you're advancing a novel oncology candidate or producing a blockbuster API, our commitment to industrial purity, transparent documentation, and responsive support ensures your synthesis runs smoothly—from milligram to metric ton.
For technical inquiries, sample requests, or bulk quotations, contact our global sales team today—and experience the difference of partnering with a true innovator in organoboron chemistry.